Delivery Order SPE2DR25D2011-SPE2DR26FADPU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,869.09 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 50 mg tablets (60-count). This competitively awarded, firm fixed-price contract requires delivery by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Briviact 50 mg tablets (60-count packages) with a ceiling value of $1,868.82. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Briviact 100 mg tablets (60-count units) with a ceiling value of $3,267.93. This firm fixed-price delivery order, which is expected to be completed by December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.48 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count package) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $1,544.72 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 100 mg tablets (60 count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 100 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,818.81. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $5,833.23 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADPUDelivery Order
The Defense Logistics Agency awarded a $10,122.88 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Briviact 100 mg tablets (60 count). This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies critical medications and medical commodities to support military and veteran healthcare systems. The company's extensive portfolio of delivery orders with DLA demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains. This contract is issued under no set-aside designation, reflecting AmerisourceBergen's competitive standing within the federal pharmaceutical supply market for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 12/15/25 |